TransMedics Group, Inc. (TMDX) NASDAQ
69.35
+1.82(+2.70%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
69.35
+1.82(+2.70%)
Currency In USD
Address
200 Minuteman Road
Andover, MA 01810
United States of America (the)
Phone
978 552 0900
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
728
First IPO Date
May 02, 2019
| Name | Title | Pay | Year Born |
| Waleed H. Hassanein | Founder, President, Chief Executive Officer & Director | 2.19M | 1968 |
| Miriam C. Provost | Vice President of Global Regulatory Affairs | 535,930 | 1961 |
| Matthew Forsyth | Senior Vice President, General Counsel & Corporate Secretary | 594,250 | N/A |
| Anil Ranganath | Advisor | 634,758 | 1982 |
| Nicholas Corcoran | Senior Vice President of Supply Chain & Operations | 865,837 | 1982 |
| Gerardo Hernandez | Chief Financial Officer & Treasurer | 1.03M | 1971 |
| Tamer I. Khayal | Senior Vice President of International | 1.04M | 1969 |
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.